Grants & Projects per year
Personal profile
Research interests
Tumor suppressor genes, the role of the p53/p73/p63 gene family in human cancer, transcription-independent mitochondrial apoptosis program of p53
Fingerprint
Dive into the research topics where Ute Moll is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
Moll, U. (PI) & Nemajerova, A. (CoPI)
National Heart Lung and Blood Institute
07/15/21 → 06/30/27
Project: Research
-
TRO Catacosinos Awards 2017 to 2025
Benach, J. (PI), Hedayati, S. (PI), Lee, C. (CoI), Moll, U. (CoI), Qu, W. (CoI), Shroyer, K. (CoI), Kaushansky, K. (PI), Boros, E. (CoI), Cattell, R. (CoI), Duong, T. (CoI), Meimetis, L. (CoI), Petrenko, A. (CoI) & Ghosh, M. (CoI)
07/1/17 → 07/15/26
Project: Research
-
Mutant p53 Gain-of-Function as an Actionable Target in Cancer Therapy
Nemajerova, A. (PI) & Moll, U. (CoPI)
09/11/20 → 06/30/26
Project: Research
-
Research Equipment Grant 2019
Hannun, Y. A. (PI), Airola, M. V. (CoPI), Luk, E. (CoPI), Martin, B. L. (CoPI), Moll, U. (CoPI), Powers, R. S. (CoPI), Carino, P. (CoPI) & Matus, D. (CoPI)
Long Island League to Abolish Cancer
06/20/19 → 07/19/20
Project: Research
-
-
Editorial Expression of Concern: p53’s mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity, (Cell Research, (2025), 35, (614), 10.1038/s41422-025-01129-0)
Wolff, S., Erster, S., Palacios, G. & Moll, U. M., Aug 2025, In: Cell Research. 35, 8, p. 614 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Editor’s Note: Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo
Talos, F., Petrenko, O., Mena, P. & Moll, U. M., Jan 15 2025, In: Cancer Research. 85, 2, p. 400 1 p.Research output: Contribution to journal › Editorial
Open Access -
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition
Isermann, T., Schneider, K. L., Wegwitz, F., De Oliveira, T., Conradi, L. C., Volk, V., Feuerhake, F., Papke, B., Stintzing, S., Mundt, B., Kühnel, F., Moll, U. M. & Schulz-Heddergott, R., Sep 2025, In: Cell Death and Differentiation. 32, 9, p. 1734-1749 16 p.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer—A Study of the GANNET53 Consortium
The entire GANNET53 consortium, Aug 1 2025, In: Clinical Cancer Research. 31, 15, p. 3160-3174 15 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Correction to: Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis (Cell Death & Differentiation, (2013), 20, 7, (898-909), 10.1038/cdd.2013.17)
Hanel, W., Marchenko, N., Xu, S., Yu, S. X., Weng, W. & Moll, U., Oct 2024, In: Cell Death and Differentiation. 31, 10, p. 1394 1 p.Research output: Contribution to journal › Comment/debate
Open Access